Investigational products should be made under applicable GMP, kept at the quality they were supplied in, used as the protocol and trial documents say, manufactured, handled and labelled so as to match treatment assignment and keep the blind, labelled according to regulations, and handled, shipped, stored, dispensed, returned and destroyed or otherwise disposed of under appropriate processes.
The graph holds this control, the 0 it maps to, and the evidence behind each claim, over MCP and REST.